Role of NLRP3 Inflammasomes in Monocyte and Microglial Recruitments in Choroidal Neovascularization
ImmunoHorizons · 2024
DOI: 10.4049/immunohorizons.2400025 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2024. Verfasst von Blake W Dieckmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Engineering, Nashville, TN. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Choroidal Neovascularization, Inflammasomes, Interleukin-1beta. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Although the pathogenesis of choroidal neovascularization (CNV) is largely unknown in age-related macular degeneration (AMD), inflammasomes may contribute to CNV development and progression. To understand the role NLRP3 inflammasomes in CNV, we used Ccr2RFPCx3cr1GFP dual-reporter mice and immunostaining techniques to confirm localization of NLRP3 inflammasomes in the laser-induced CNV (LCNV) lesions. Confocal microscopy was used to image and quantify LCNV volumes. MCC950 was used as NLRP3 inhibitor. ELISA and quantitative RT-PCR were used to confirm the activation of NLRP3 by monitoring the expression of IL-1β protein and mRNA in choroidal tissues from LCNV mice. In addition, NLRP3 (−/−) LCNV mice were used to investigate whether NLRP3 inflammasomes contribute to the development of LCNV lesions. We observed that red fluorescent protein (RFP)–positive monocyte-derived macrophages and GFP-positive microglia-derived macrophages, in addition to other cell types, were localized in LCNV lesions at day 7 post–laser injury. In addition, NLRP3 inflammasomes are associated with LCNV lesions. Inhibition of NLRP3 inflammasomes, using MCC950, caused an increased Ccr2RFP-positive macrophages, Cx3cr1GFP-positive microglia, and other cells, resulting in an increase in total lesion size. NLRP3 (−/−) LCNV mice showed significantly increased lesion size compared with age-matched controls. Inhibition of NLRP3 resulted in decreased IL-1β mRNA and protein expression in the choroidal tissues, suggesting that increased lesion size may not be directly related to IL-1β.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Engineering, Nashville, TN.
- Department of Biomedical Engineering, Vanderbilt University, Nashville, TN.
ORCID-Profile: Marcell E Paguaga, John S Penn, Md Imam Uddin
Förderung
- NEI NIH HHS
Zitieren
APA
Dieckmann, B. W., Paguaga, M. E., McCollum, G. W., Penn, J. S., & Uddin, M. I. (2024). Role of NLRP3 Inflammasomes in Monocyte and Microglial Recruitments in Choroidal Neovascularization. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2400025
Vancouver
Dieckmann BW, Paguaga ME, McCollum GW, Penn JS, Uddin MI. Role of NLRP3 Inflammasomes in Monocyte and Microglial Recruitments in Choroidal Neovascularization. ImmunoHorizons. 2024. doi:10.4049/immunohorizons.2400025
BibTeX
@article{Dieckmann2024,
author = {Dieckmann, Blake W and Paguaga, Marcell E and McCollum, Gary W and Penn, John S and Uddin, Md Imam},
title = {Role of NLRP3 Inflammasomes in Monocyte and Microglial Recruitments in Choroidal Neovascularization},
journal = {ImmunoHorizons},
year = {2024},
doi = {10.4049/immunohorizons.2400025}
}
EUVIMED